electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rhea-AI Summary

electroCore (NASDAQ: ECOR) announced two executive hires and inducement equity grants effective April 2026. Seth Abrams will join as VP, Sales on April 1, 2026, and Michael Fox will join as Chief Operating Officer on April 13, 2026.

The Compensation Committee granted 30,000 RSUs to Abrams and 70,000 RSUs to Fox under NASDAQ Listing Rule 5635(c)(4). The RSUs vest one-third on each of the first, second and third anniversaries of grant and will be settled in common stock upon vesting, subject to continued employment.

Positive

• Hired VP Sales Seth Abrams, effective April 1, 2026
• Hired COO Michael Fox, effective April 13, 2026
• Granted a total of 100,000 RSUs (30,000 + 70,000) as inducements

Negative

• RSUs vest one-third annually over three years, delaying full ownership

Key Figures

RSUs to VP Sales: 30,000 RSUs RSUs to COO: 70,000 RSUs RSU vesting schedule: One-third annually over 3 years +2 more

5 metrics

RSUs to VP Sales 30,000 RSUs Inducement grant to Seth Abrams upon employment commencement

RSUs to COO 70,000 RSUs Inducement grant to Michael Fox upon employment commencement

RSU vesting schedule One-third annually over 3 years Vesting on first, second, and third anniversaries of grant date

Abrams start date April 1, 2026 Effective date for VP, Sales joining electroCore

Fox start date April 13, 2026 Effective date for Chief Operating Officer joining electroCore

Market Reality Check

Price: $5.64 Vol: Volume 18,334 is well bel...

low vol

$5.64 Last Close

Volume Volume 18,334 is well below the 20-day average of 64,564, indicating muted trading ahead of this announcement. low

Technical Shares at $5.64 are trading slightly below the 200-day MA of $5.71 and about 35% above the 52-week low.

Peers on Argus

Sector peers showed mixed moves, with names like MODD and MYO down while RBOT an...

2 Up 1 Down

Sector peers showed mixed moves, with names like MODD and MYO down while RBOT and IINN were up. Combined with momentum data showing both up and down movers, this points to stock-specific trading rather than a unified sector trend.

Historical Context

5 past events · Latest: Mar 19 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 19	Full-year earnings	Positive	-4.7%	Record 2025 net sales, improved adjusted EBITDA, leadership transition details.
Mar 10	Conference participation	Neutral	-2.1%	Participation in 38th Annual Roth Conference and investor meetings.
Mar 09	Earnings date notice	Neutral	-3.1%	Announcement of Q4 and FY2025 results release and investor webinar timing.
Jan 21	Clinical study news	Positive	+10.2%	New PTSD study using gammaCore Sapphire as adjunctive treatment.
Jan 20	Preliminary results	Positive	-3.6%	Preliminary 2025 revenue guidance showing strong year-over-year growth.

Pattern Detected

Positive financial updates have previously seen negative next-day reactions, while product/clinical news has drawn more favorable responses.

Recent Company History

Recent news for ECOR highlighted strong growth but ongoing losses. On Mar 19, full-year 2025 results showed record net sales and improved adjusted EBITDA, yet the stock fell. Earlier in January, preliminary 2025 revenue guidance also coincided with a decline, despite double-digit growth. In contrast, the Jan 21 PTSD study using gammaCore Sapphire drew a strong positive reaction. Today’s inducement RSU grants for new sales and operations leaders fit into the broader leadership transition already disclosed in recent filings.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-10-03

An effective resale registration filed on Oct 3, 2025 covers up to 762,508 common shares for selling stockholders. The company is not issuing new securities or receiving proceeds from these resales, but registered holders have flexibility to sell into the market over time.

Market Pulse Summary

This announcement details equity inducement grants tied to hiring a new VP of Sales and a COO, with ...

Analysis

This announcement details equity inducement grants tied to hiring a new VP of Sales and a COO, with a total of 100,000 RSUs vesting over three years. It follows earlier disclosures of leadership changes and ongoing growth initiatives. Investors may focus on how these commercial and operational leaders influence revenue execution and cost discipline over time, while also monitoring existing registration arrangements for resales and previously highlighted balance sheet and governance risks in recent SEC filings.

Key Terms

restricted stock units, rsus, nasdaq listing rule 5635(c)(4)

3 terms

restricted stock units financial

"The Compensation Committee ... granted 30,000 restricted stock units (“RSUs”) to Mr. Abrams"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

rsus financial

"30,000 restricted stock units (“RSUs”) to Mr. Abrams and 70,000 RSUs to Mr. Fox"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

nasdaq listing rule 5635(c)(4) regulatory

"The RSUs were granted as an inducement ... pursuant to NASDAQ Listing Rule 5635(c)(4)."

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. Not financial advice.

ROCKAWAY, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Seth Abrams will join electroCore, effective April 1, 2026, as the Company’s VP, Sales, and Michael Fox will join electroCore, effective April 13, 2026, as the Company's Chief Operating Officer. The Compensation Committee of electroCore’s Board of Directors granted 30,000 restricted stock units (“RSUs”) to Mr. Abrams and 70,000 RSUs to Mr. Fox in connection with the commencement of their employment. The RSUs were granted as an inducement material to their commencement of employment pursuant to NASDAQ Listing Rule 5635(c)(4). In general, one-third of the RSUs will vest on each of the first, second and third anniversaries of the date of grant, subject to each individual's continued employment by the Company on the applicable vesting date. Upon vesting, the RSUs shall be settled in shares of the Company’s common stock.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic technology company whose mission is to electroCore, Inc. and its subsidiaries (“electroCore” or the “Company”) is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products to treat chronic pain syndromes through non-invasive neuromodulation technology are gammaCore non-invasive vagus nerve stimulation, or nVNS, and the Quell® Fibromyalgia. Additionally, the Company commercializes its handheld and personal use Trvuaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com.

Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com

FAQ

Who will join electroCore (ECOR) as VP, Sales and when will Seth Abrams start?

Seth Abrams will join as VP, Sales effective April 1, 2026. According to electroCore, the Compensation Committee granted him 30,000 RSUs as an inducement tied to his employment commencement.

When does Michael Fox start as Chief Operating Officer at electroCore (ECOR)?

Michael Fox will join as COO effective April 13, 2026. According to electroCore, he received 70,000 RSUs as an inducement, subject to vesting and settlement in common stock.

How many total RSUs did electroCore (ECOR) grant for these new hires and under which rule?

electroCore granted a total of 100,000 RSUs (30,000 to Abrams and 70,000 to Fox). According to electroCore, grants were made under NASDAQ Listing Rule 5635(c)(4) as inducements.

What is the vesting schedule for the RSUs granted by electroCore (ECOR)?

The RSUs vest one-third on each of the first, second and third anniversaries of the grant date. According to electroCore, vesting is subject to each individual's continued employment on each vesting date.

Will the electroCore (ECOR) RSUs convert to shares on vesting and how?

Yes. According to electroCore, upon vesting the RSUs shall be settled in shares of the company's common stock, subject to the stated vesting schedule and continued employment.

Why were the RSUs granted to new executives at electroCore (ECOR)?

The RSUs were granted as inducements material to the commencement of employment under NASDAQ rules. According to electroCore, the grants are tied to starting employment and intended to align incentives.